Novo Nordisk A/S - share repurchase programme
08 avr. 2024 09h40 HE
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 08 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Novo Nordisk A/S - share repurchase programme
02 avr. 2024 06h56 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
25 mars 2024 07h58 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
25 mars 2024 05h59 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...
Vedtægter for Novo Nordisk A/S 2024
25 mars 2024 03h51 HE
|
Novo Nordisk A/S
Vedtægter for Novo Nordisk A/S 2024
Vedhæftet fil
Vedtægter 21 Mar 2024
...
Novo Nordisk A/S - Articles of Association 2024
25 mars 2024 03h51 HE
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association 2024
Attachment
Articles of Association 21 Mar 2024
...
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
21 mars 2024 11h55 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 21 March 2024 – Novo Nordisk today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending...
Resolutions from the Annual General Meeting of Novo Nordisk A/S
21 mars 2024 10h59 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 21 March 2024 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, chair of the Board of Directors communicated: “We are very...
Novo Nordisk A/S - share repurchase programme
18 mars 2024 10h18 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 18 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
11 mars 2024 08h46 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 11 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...